CLOVER ANNOUNCES POSITIVE PHASE 2 CLINICAL DATA FOR RSV + HMPV ± PIV3 RESPIRATORY COMBINATION VACCINE CANDIDATES IN OLDER ADULTS

Reuters · 1d ago

Please log in to view news